| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.
|
N Engl J Med
|
2004
|
11.29
|
|
2
|
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.
|
J Clin Invest
|
2006
|
4.51
|
|
3
|
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
|
Blood
|
2004
|
3.61
|
|
4
|
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
|
J Clin Oncol
|
2010
|
2.99
|
|
5
|
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
|
Blood
|
2008
|
2.34
|
|
6
|
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
|
J Clin Oncol
|
2010
|
2.31
|
|
7
|
Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation.
|
Stem Cells Dev
|
2014
|
2.27
|
|
8
|
Concise review: hitting the right spot with mesenchymal stromal cells.
|
Stem Cells
|
2010
|
2.25
|
|
9
|
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.
|
Blood
|
2002
|
2.14
|
|
10
|
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
|
Proc Natl Acad Sci U S A
|
2009
|
2.02
|
|
11
|
Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium.
|
J Clin Invest
|
2009
|
1.75
|
|
12
|
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
|
Blood
|
2009
|
1.70
|
|
13
|
Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy.
|
PLoS One
|
2009
|
1.64
|
|
14
|
Defining the risks of mesenchymal stromal cell therapy.
|
Cytotherapy
|
2010
|
1.60
|
|
15
|
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
|
Biol Blood Marrow Transplant
|
2006
|
1.58
|
|
16
|
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
|
Blood
|
2002
|
1.57
|
|
17
|
An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential.
|
Blood
|
2010
|
1.56
|
|
18
|
Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
|
Stem Cells
|
2008
|
1.54
|
|
19
|
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors.
|
Leuk Lymphoma
|
2012
|
1.47
|
|
20
|
Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes?
|
Circ Res
|
2008
|
1.46
|
|
21
|
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.
|
Blood
|
2007
|
1.43
|
|
22
|
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
|
Blood
|
2008
|
1.42
|
|
23
|
Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction.
|
Basic Res Cardiol
|
2011
|
1.40
|
|
24
|
How I treat relapsed and refractory Hodgkin lymphoma.
|
Blood
|
2011
|
1.36
|
|
25
|
Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.
|
Eur Urol
|
2010
|
1.32
|
|
26
|
Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats.
|
Cell Transplant
|
2008
|
1.25
|
|
27
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.
|
Biol Blood Marrow Transplant
|
2008
|
1.16
|
|
28
|
Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients.
|
Hematology
|
2005
|
1.14
|
|
29
|
Facing the NIH funding crisis: how professional societies can help.
|
JAMA
|
2012
|
1.14
|
|
30
|
Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.
|
PLoS One
|
2010
|
1.13
|
|
31
|
Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury.
|
FASEB J
|
2007
|
1.11
|
|
32
|
Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
|
J Clin Oncol
|
2005
|
1.08
|
|
33
|
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission.
|
Br J Haematol
|
2002
|
1.06
|
|
34
|
Mesenchymal stromal cells for graft-versus-host disease.
|
Hum Gene Ther
|
2011
|
1.04
|
|
35
|
ABO blood group barrier in allogeneic bone marrow transplantation revisited.
|
Biol Blood Marrow Transplant
|
2005
|
1.04
|
|
36
|
Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model.
|
PLoS One
|
2011
|
1.02
|
|
37
|
Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
|
Cytotherapy
|
2011
|
1.01
|
|
38
|
KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
|
Exp Hematol
|
2005
|
0.98
|
|
39
|
Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research.
|
Br J Haematol
|
2006
|
0.98
|
|
40
|
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma.
|
Cancer
|
2006
|
0.97
|
|
41
|
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
|
Biol Blood Marrow Transplant
|
2008
|
0.97
|
|
42
|
Airway regeneration: the role of the Clara cell secretory protein and the cells that express it.
|
Cytotherapy
|
2009
|
0.96
|
|
43
|
Oligodendrocytes and radial glia derived from adult rat spinal cord progenitors: morphological and immunocytochemical characterization.
|
J Histochem Cytochem
|
2006
|
0.96
|
|
44
|
Relearning the lessons of genomic stability of human cells during expansion in culture: implications for clinical research.
|
Stem Cells
|
2012
|
0.96
|
|
45
|
Differences in origin of reactive microglia in bone marrow chimeric mouse and rat after transient global ischemia.
|
J Neuropathol Exp Neurol
|
2011
|
0.96
|
|
46
|
Analysis of green fluorescent protein expression in transgenic rats for tracking transplanted neural stem/progenitor cells.
|
J Histochem Cytochem
|
2005
|
0.95
|
|
47
|
Immuno-polymeric nanoparticles by Diels-Alder chemistry.
|
Angew Chem Int Ed Engl
|
2007
|
0.95
|
|
48
|
Hematopoiesis in the elderly.
|
Hematology
|
2004
|
0.94
|
|
49
|
Effect of radiation and cell implantation on wound healing in a rat model.
|
J Surg Oncol
|
2003
|
0.92
|
|
50
|
Enhancing research in regenerative medicine.
|
Blood
|
2010
|
0.92
|
|
51
|
Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.
|
Haematologica
|
2012
|
0.92
|
|
52
|
Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI.
|
Cancer Immunol Immunother
|
2012
|
0.91
|
|
53
|
Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow.
|
Cancer Res
|
2007
|
0.91
|
|
54
|
Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery.
|
Surg Neurol
|
2008
|
0.90
|
|
55
|
Acute myeloid leukemia.
|
Hematology Am Soc Hematol Educ Program
|
2002
|
0.89
|
|
56
|
Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation.
|
J Immunol
|
2012
|
0.89
|
|
57
|
Brief report: The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells.
|
Stem Cells
|
2013
|
0.89
|
|
58
|
Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1.
|
FASEB J
|
2009
|
0.89
|
|
59
|
Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.
|
Biol Blood Marrow Transplant
|
2002
|
0.88
|
|
60
|
rbm47, a novel RNA binding protein, regulates zebrafish head development.
|
Dev Dyn
|
2013
|
0.88
|
|
61
|
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.
|
Br J Haematol
|
2003
|
0.87
|
|
62
|
Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.
|
Biol Blood Marrow Transplant
|
2009
|
0.86
|
|
63
|
Concise review: bone marrow autotransplants for liver disease?
|
Stem Cells
|
2013
|
0.85
|
|
64
|
Salvage therapy for relapsed/refractory diffuse large B cell lymphoma.
|
Biol Blood Marrow Transplant
|
2008
|
0.85
|
|
65
|
A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2007
|
0.85
|
|
66
|
Constitutively polarized granules prime KHYG-1 NK cells.
|
Int Immunol
|
2006
|
0.84
|
|
67
|
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
|
Biol Blood Marrow Transplant
|
2006
|
0.84
|
|
68
|
Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
|
Cytometry B Clin Cytom
|
2006
|
0.83
|
|
69
|
Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2008
|
0.83
|
|
70
|
Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma.
|
Cancer
|
2006
|
0.83
|
|
71
|
Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction.
|
Cell Transplant
|
2012
|
0.83
|
|
72
|
Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarction.
|
Circulation
|
2012
|
0.83
|
|
73
|
Is there a role for autotransplants in AML in first remission?
|
Biol Blood Marrow Transplant
|
2009
|
0.82
|
|
74
|
Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2012
|
0.82
|
|
75
|
Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.
|
Cytotherapy
|
2010
|
0.82
|
|
76
|
Mesenchymal stromal cells as supportive cells for hepatocytes.
|
Mol Ther
|
2009
|
0.81
|
|
77
|
Cell-based therapies for osteonecrosis of the femoral head.
|
Biol Blood Marrow Transplant
|
2008
|
0.81
|
|
78
|
Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis.
|
Stem Cells Dev
|
2014
|
0.81
|
|
79
|
Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model.
|
Stem Cells Transl Med
|
2013
|
0.80
|
|
80
|
Advances in targeted therapy for chronic myeloid leukemia.
|
Expert Rev Anticancer Ther
|
2003
|
0.80
|
|
81
|
Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma.
|
Haematologica
|
2010
|
0.80
|
|
82
|
Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway.
|
Cytotherapy
|
2013
|
0.79
|
|
83
|
Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.
|
Stem Cell Rev
|
2014
|
0.79
|
|
84
|
Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
|
Leuk Lymphoma
|
2009
|
0.79
|
|
85
|
Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model.
|
Interact Cardiovasc Thorac Surg
|
2012
|
0.79
|
|
86
|
Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.
|
J Biol Chem
|
2011
|
0.78
|
|
87
|
Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation.
|
Exp Hematol
|
2002
|
0.77
|
|
88
|
An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.
|
Ann Am Thorac Soc
|
2015
|
0.77
|
|
89
|
Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.77
|
|
90
|
Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-review.
|
Gerontology
|
2008
|
0.77
|
|
91
|
Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein.
|
Transgenic Res
|
2014
|
0.76
|
|
92
|
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.
|
Hematology
|
2006
|
0.76
|
|
93
|
Uterine-derived stem cells reconstitute the bone marrow of irradiated mice.
|
Stem Cells Dev
|
2015
|
0.76
|
|
94
|
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy.
|
Haematologica
|
2011
|
0.75
|
|
95
|
When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes.
|
Haematologica
|
2013
|
0.75
|
|
96
|
The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant.
|
Support Care Cancer
|
2001
|
0.75
|
|
97
|
Overcoming the challenges of conducting translational research in cell therapy.
|
Front Med
|
2011
|
0.75
|
|
98
|
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
|
Leuk Lymphoma
|
2005
|
0.75
|
|
99
|
Older patients with acute myeloid leukemia.
|
Expert Rev Hematol
|
2010
|
0.75
|
|
100
|
Acute promyelocytic leukemia: a case-based review.
|
Hematology
|
2003
|
0.75
|
|
101
|
The effect of local breast radiotherapy on circulating CD34(+) cells.
|
Radiother Oncol
|
2011
|
0.75
|
|
102
|
Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repair.
|
Curr Opin Organ Transplant
|
2017
|
0.75
|
|
103
|
The principles and overview of autologous hematopoietic stem cell transplantation.
|
Cancer Treat Res
|
2009
|
0.75
|
|
104
|
Dr. Ernest McCulloch.
|
Stem Cells Dev
|
2011
|
0.75
|
|
105
|
Preparing for the unthinkable: emergency preparedness for the hematopoietic cell transplant program.
|
Biol Blood Marrow Transplant
|
2006
|
0.75
|
|
106
|
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
|
Br J Haematol
|
2014
|
0.75
|
|
107
|
Mesenchymal Stem Cell Stimulation of Breast Cancer Proliferation Is Dependent on Both Stem Cell Source and Tumor Type.
|
Plast Reconstr Surg
|
2015
|
0.75
|